相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Do Case-Control Studies Always Estimate Odds Ratios?
Jeremy A. Labrecque et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2021)
Metformin and health outcomes: An umbrella review of systematic reviews with meta-analyses
Xue Li et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2021)
The Current and Potential Therapeutic Use of Metformin-The Good Old Drug
Jozef Drzewoski et al.
PHARMACEUTICALS (2021)
More recent, better designed studies have weakened links between antidiabetes medications and cancer risk
R. Dankner et al.
DIABETIC MEDICINE (2020)
Benefits of Metformin in Attenuating the Hallmarks of Aging
Ameya S. Kulkarni et al.
CELL METABOLISM (2020)
The quest to slow ageing through drug discovery
Linda Partridge et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Metformin and COVID-19: From cellular mechanisms to reduced mortality
A. J. Scheen
DIABETES & METABOLISM (2020)
From discoveries in ageing research to therapeutics for healthy ageing
Judith Campisi et al.
NATURE (2019)
The Danish Twin Registry: An Updated Overview
Dorthe Almind Pedersen et al.
TWIN RESEARCH AND HUMAN GENETICS (2019)
TAME: A Genuinely Good Use of 75 Million Dollars
Aubrey D. N. J. de Grey
REJUVENATION RESEARCH (2019)
Repurposing Metformin for Cardiovascular Disease
Graham Rena et al.
CIRCULATION (2018)
Anti-ageing pipeline starts to mature
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2018)
Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Aidin Rawshani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Cardiovascular events and all-cause mortality associated with sulphonylureas compared with other antihyperglycaemic drugs: A Bayesian meta-analysis of survival data
Steve Bain et al.
DIABETES OBESITY & METABOLISM (2017)
Prevalent new-user cohort designs for comparative drug effect studies by time-conditional propensity scores
Samy Suissa et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2017)
Metformin to Treat Cancer Misstep in Translational Research from Observational Studies
Samy Suissa
EPIDEMIOLOGY (2017)
Metformin and cancer in type 2 diabetes: a systematic review and comprehensive bias evaluation (vol 46, pg 728, 2017
Ruth E. Farmer et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2017)
Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes
Aidin Rawshani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Metformin: historical overview
Clifford J. Bailey
DIABETOLOGIA (2017)
Repurposing metformin for the prevention of cancer and cancer recurrence
Brandy M. Heckman-Stoddard et al.
DIABETOLOGIA (2017)
Sulfonylureas and the Risks of Cardiovascular Events and Death: A Methodological Meta-Regression Analysis of the Observational Studies
Laurent Azoulay et al.
DIABETES CARE (2017)
Cardiovascular safety of non-insulin pharmacotherapy for type 2 diabetes
James Xu et al.
CARDIOVASCULAR DIABETOLOGY (2017)
Comparison of Statistical Approaches for Dealing With Immortal Time Bias in Drug Effectiveness Studies
Mohammad Ehsanul Karim et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2016)
Type 2 Diabetes Genetic Predisposition, Obesity, and All-Cause Mortality Risk in the US: A Multiethnic Analysis
Aaron Leong et al.
DIABETES CARE (2016)
Comparison of Clinical Outcomes and Adverse Events Associated With Glucose-Lowering Drugs in Patients With Type 2 Diabetes A Meta-analysis
Suetonia C. Palmer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
The Danish Adult Diabetes Registry
Marit Eika Jorgensen et al.
CLINICAL EPIDEMIOLOGY (2016)
Morbidity and medicine prescriptions in a nationwide Danish population of patients diagnosed with polycystic ovary syndrome
Dorte Glintborg et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2015)
Anti-ageing pill pushed as bona fide drug
Erika Check Hayden
NATURE (2015)
Healthy aging: The ultimate preventative medicine
Matt Kaeberlein et al.
SCIENCE (2015)
Metformin: From Mechanisms of Action to Therapies
Marc Foretz et al.
CELL METABOLISM (2014)
Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls
C. A. Bannister et al.
DIABETES OBESITY & METABOLISM (2014)
The Danish Civil Registration System as a tool in epidemiology
Morten Schmidt et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2014)
Association of metformin use with cancer incidence and mortality: A meta-analysis
Pengpeng Zhang et al.
CANCER EPIDEMIOLOGY (2013)
Metformin and the Risk of Cancer Time-related biases in observational studies
Samy Suissa et al.
DIABETES CARE (2012)
Cancer Risk in Diabetic Patients Treated with Metformin: A Systematic Review and Meta-analysis
Hiroshi Noto et al.
PLOS ONE (2012)
Updating and Validating the Charlson Comorbidity Index and Score for Risk Adjustment in Hospital Discharge Abstracts Using Data From 6 Countries
Hude Quan et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2011)
Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death
Sreenivasa Rao Kondapally Seshasai et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Danish education registers
Vibeke M. Jensen et al.
SCANDINAVIAN JOURNAL OF PUBLIC HEALTH (2011)
Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis
Andrea DeCensi et al.
CANCER PREVENTION RESEARCH (2010)
Familial Risks for Type 2 Diabetes in Sweden
Kari Hemminki et al.
DIABETES CARE (2010)
Metformin: Taking away the candy for cancer?
Mathilde Jalving et al.
EUROPEAN JOURNAL OF CANCER (2010)
Causal Inference and Observational Research: The Utility of Twins
Matt McGue et al.
PERSPECTIVES ON PSYCHOLOGICAL SCIENCE (2010)
10-year follow-up of intensive glucose control in type 2 diabetes
Rury R. Holman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
分享论文
